—Boulder, CO-based Miragen Therapeutics will go public via a reverse merger with diagnostics developer Signal Genetics (NASDAQ: SGNL).
Growth Capitalist (https://growthcapitalist.com/2016/11/bio-roundup-clinical-shirkers-amd-worriers-ash-fallers-more/)
—Boulder, CO-based Miragen Therapeutics will go public via a reverse merger with diagnostics developer Signal Genetics (NASDAQ: SGNL).